Accuracy assessment of pharmacogenetic algorithms for warfarin dose prediction in Chinese patients

被引:8
作者
Lei, Xiaoying [1 ]
Guo, Yanhai [1 ]
Sun, Jianbin [1 ]
Zhou, Heping [2 ]
Liu, Yonglan [1 ]
Liang, Ping [1 ]
Yan, Zhen [1 ]
机构
[1] Fourth Mil Med Univ, Dept Pharmacogen, Sch Pharm, State Key Lab Canc Biol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China
关键词
DOSING ALGORITHMS; MULTIETHNIC POPULATION; ORAL ANTICOAGULATION; CYP2C9; GENOTYPES; RANDOMIZED-TRIAL; THERAPY; VKORC1; DOSAGE; POLYMORPHISMS; REQUIREMENT;
D O I
10.1002/ajh.23151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A few warfarin pharmacogenetic dosing algorithms have been proposed, based on multiethnic or homogeneous populations, to estimate warfarin therapeutic doses. However, it remains to be proven that which algorithm is accurate in predicting warfarin dose in Chinese people. We selected eight warfarin dose predictive pharmacogenetic algorithms and retrospectively assessed the predictive accuracy of each algorithm in a total of 368 eligible outpatients by comparing the actual stable therapeutic dose to the dose predicted by the algorithm. Our results showed that a high level of performance was demonstrated by three algorithms, Gage et al., Anderson et al., and Wu et al., having a similar performance in coefficient of determination (R 2) and percentage of patients predicted dose within 20% of actual dose. The Gage et al. algorithm had the lowest mean absolute error (MAE). These results indicated that the algorithm by Gage et al. provided a more accurate prediction than did the others, which suggests that this pharmacogenetic algorithm might be used in clinical practice to guide rational administration of warfarin.
引用
收藏
页码:541 / 544
页数:4
相关论文
共 29 条
  • [1] Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis
    Anand, SS
    Yusuf, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2058 - 2067
  • [2] Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
    Anderson, Jeffrey L.
    Horne, Benjamin D.
    Stevens, Scott M.
    Grove, Amanda S.
    Barton, Stephanie
    Nicholas, Zachery P.
    Kahn, Samera F. S.
    May, Heidi T.
    Samuelson, Kent M.
    Muhlestein, Joseph B.
    Carlquist, John F.
    [J]. CIRCULATION, 2007, 116 (22) : 2563 - 2570
  • [3] Chinese patients require lower dosage of warfarin
    Cheng, Tsung O.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 139 (01) : 1 - 1
  • [4] Chenhsu RY, 2000, ANN PHARMACOTHER, V34, P1395
  • [5] Low dose oral anticoagulation therapy in Chinese children with congenital heart disease
    Cheung, YF
    Leung, MP
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1998, 34 (06) : 563 - 567
  • [6] The influence of ethnicity on warfarin dosage requirement
    Dang, MTN
    Hambleton, J
    Kayser, SR
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (06) : 1008 - 1012
  • [7] Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
    Gage, B. F.
    Eby, C.
    Johnson, J. A.
    Deych, E.
    Rieder, M. J.
    Ridker, P. M.
    Milligan, P. E.
    Grice, G.
    Lenzini, P.
    Rettie, A. E.
    Aquilante, C. L.
    Grosso, L.
    Marsh, S.
    Langaee, T.
    Farnett, L. E.
    Voora, D.
    Veenstra, D. L.
    Glynn, R. J.
    Barrett, A.
    McLeod, H. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 326 - 331
  • [8] Racial background is a determinant factor in the maintenance dosage of warfarin
    Gan, GG
    Teh, A
    Goh, KY
    Chong, HT
    Pang, KW
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (01) : 84 - 86
  • [9] Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2006-2007 Joint Working Groups Report), 2008, CIRC J S4, V72, P1581
  • [10] Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients
    Huang, Sheng-Wen
    Chen, Hai-Sheng
    Wang, Xian-Qun
    Huang, Ling
    Xu, Ding-Li
    Hu, Xiao-Jia
    Huang, Zhi-Hui
    He, Yong
    Chen, Kai-Ming
    Xiang, Dao-Kang
    Zou, Xiao-Ming
    Li, Qinag
    Ma, Li-Qin
    Wang, Hao-Fei
    Chen, Bao-Lin
    Li, Liang
    Jia, Yan-Kai
    Xu, Xiang-Min
    [J]. PHARMACOGENETICS AND GENOMICS, 2009, 19 (03) : 226 - 234